| Issue Date | Title | Author(s) | Type | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2014 | 3,4-Dihydroxytoluene, a metabolite of rutin, inhibits inflammatory responses in lipopolysaccharide-activated macrophages by reducing the activation of NF-κB signaling | KANG-YI SU ; Yu C.Y.; Chen Y.-P.; Hua K.-F.; Chen Y.-L.S. | Journal Article | 28 | 25 | |
| 2018 | Application of single nucleotide extension and MALDI-TOF mass spectrometry in proofreading and DNA repair assay | KANG-YI SU ; Lai H.-M.; Goodman S.D.; Hu W.-Y.; Cheng W.-C.; Lin L.-I.; Yang Y.-C.; Fang W.-H. | Journal Article | 4 | 4 | |
| 2020 | Association between programmed death-ligand 1 expression, immune microenvironments, and clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients treated with tyrosine kinase inhibitors | Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; KANG-YI SU ; Chang Y.-L.; Wu C.-T.; Hsu C.-C.; Liao B.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. | Journal Article | 1 | 2 | |
| 2018 | The association of acquired T790M mutation with clinical characteristics after resistance to first-line epidermal growth factor receptor tyrosine kinase inhibitor in lung adenocarcinoma | Huang Y.-H.; Hsu K.-H.; Tseng J.-S.; Chen K.-C.; Hsu C.-H.; KANG-YI SU ; Chen J.J.W.; Chen H.-W.; Yu S.-L.; Yang T.-Y.; Chang G.-C. | Journal Article | 9 | 7 | |
| 2020 | Association of Programmed Death-Ligand 1 Expression with Fusion Variants and Clinical Outcomes in Patients with Anaplastic Lymphoma Kinase-Positive Lung Adenocarcinoma Receiving Crizotinib | Yang C.-Y.; Liao W.-Y.; Ho C.-C.; Chen K.-Y.; Tsai T.-H.; Hsu C.-L.; Liu Y.-N.; KANG-YI SU ; Chang Y.-L.; Wu C.-T.; Liao B.-C.; Hsu C.-C.; Hsu W.-H.; Lee J.-H.; Lin C.-C.; Shih J.-Y.; Yang J.C.-H.; Yu C.-J. | Journal Article | 0 | 0 | |
| 2018 | Characteristics and Predictive Value of PD-L1 Status in Real-World NonSmall Cell Lung Cancer Patients | Tseng J.-S.; Yang T.-Y.; Wu C.-Y.; Ku W.-H.; Chen K.-C.; Hsu K.-H.; Huang Y.-H.; KANG-YI SU ; Yu S.-L.; Chang G.-C. | Journal Article | 6 | 4 | |
| 2018 | Clinicopathological and genomic comparisons between different histologic components in combined small cell lung cancer and non-small cell lung cancer | Lin M.-W.; KANG-YI SU ; Su T.-J.; Chang C.-C.; Lin J.-W.; Lee Y.-H.; Yu S.-L.; Chen J.-S.; Hsieh M.-S. | Journal Article | 4 | 3 | |
| 2011 | Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations | Yuan S.; Yu S.-L.; Chen H.-Y.; Hsu Y.-C.; KANG-YI SU ; Chen H.-W.; Chen C.-Y.; Yu C.-J.; Shih J.-Y.; Chang Y.-L.; Cheng C.-L.; Hsu C.-P.; Hsia J.-Y.; Lin C.-Y.; Wu G.; Liu C.-H.; Wang C.-D.; Yang K.-C.; Chen Y.-W.; Lai Y.-L.; Hsu C.-C.; Lin T.-C.; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen J.J.W.; Chang G.-C.; Li K.-C.; Yang P.-C. | Journal Article | 23 | 22 | |
| 2016 | Coexistence of EGFR T790M mutation and common activating mutations in pretreatment non-small cell lung cancer: A systematic review and meta-analysis | Chen L.-Y.; Molina-Vila M.A.; Ruan S.-Y.; KANG-YI SU ; Liao W.-Y.; Yu K.-L.; Ho C.-C.; Shih J.-Y.; Yu C.-J.; Yang J.C.H.; Rosell R.; Yang P.-C. | Journal Article | 40 | 38 | |
| 2006 | Decreased expressions of hepsin in human hepatocellular carcinomas | Chen C.-H.; KANG-YI SU ; Tao M.-H.; Lin S.-W.; Su Y.-H.; Tsai Y.-C.; Cheng K.-C.; Jeng Y.-M.; Sheu J.-C. | Journal Article | 13 | 15 | |
| 2016 | Dichloromethane extracts of propolis protect cell from oxygenglucose deprivation-induced oxidative stress via reducing apoptosis | Sun L.-P.; Xu X.; Hwang H.-H.; Wang X.; KANG-YI SU ; Chen Y.-L.S. | Journal Article | 8 | 7 | |
| 2018 | DNA polymerase I proofreading exonuclease activity is required for endonuclease V repair pathway both in vitro and in vivo | KANG-YI SU ; Lin L.-I.; Goodman S.D.; Yen R.-S.; Wu C.-Y.; Chang W.-C.; Yang Y.-C.; Cheng W.-C.; Fang W.-H. | Journal Article | 4 | 4 | |
| 2015 | Dynamic plasma EGFR mutation status as a predictor of EGFR-TKI efficacy in patients with EGFR-mutant lung adenocarcinoma | Tseng J.-S.; Yang T.-Y.; Tsai C.-R.; Chen K.-C.; Hsu K.-H.; Tsai M.-H.; Yu S.-L.; KANG-YI SU ; Chen J.J.W.; Chang G.-C. | Journal Article | 44 | 45 | |
| 2015 | EGFR mutation and lobar location of lung adenocarcinoma | Tseng C.-H.; Chen K.-C.; Hsu K.-H.; Tseng J.-S.; Ho C.-C.; Hsia T.-C.; KANG-YI SU ; Wu M.-F.; Chiu K.-L.; Liu C.-M.; Wu T.-C.; Chen H.-J.; Chen H.-Y.; Chang C.-S.; Hsu C.-P.; Hsia J.-Y.; Chuang C.-Y.; Lin C.-H.; Chen J.J.W.; Chen K.-Y.; Liao W.-Y.; Shih J.-Y.; Yu S.-L.; Yu C.-J.; Yang P.-C.; Yang T.-Y.; Chang G.-C. | Journal Article | 4 | 4 | |
| 2017 | EGFR mutation, smoking, and gender in advanced lung adenocarcinoma | Tseng C.-H.; Chiang C.-J.; Tseng J.-S.; Yang T.-Y.; Hsu K.-H.; Chen K.-C.; Wang C.-L.; Chen C.-Y.; Yen S.H.; Tsai C.-M.; Huang M.-S.; Ho C.-C.; Yu C.-J.; Tsai Y.-H.; Chen J.-S.; Chou T.-Y.; Tsai M.-H.; Chen H.-Y.; KANG-YI SU ; Chen J.J.W.; Chen H.-W.; Yu S.-L.; Liu T.-W.; Chang G.-C. | Journal Article | 23 | 0 | |
| 2016 | The emergence of T790M mutation in EGFR-mutant lung adenocarcinoma patients having a history of acquired resistance to EGFR-TKI: Focus on rebiopsy timing and long-term existence of T790M | Tseng J.-S.; KANG-YI SU ; Yang T.-Y.; Chen K.-C.; Hsu K.-H.; Chen H.-Y.; Tsai C.-R.; Yu S.-L.; Chang G.-C. | Journal Article | 10 | 10 | |
| 2011 | Enterovirus-induced miR-141 contributes to shutoff of host protein translation by targeting the translation initiation factor eIF4E | Ho B.-C.; Yu S.-L.; Chen J.J.W.; Chang S.-Y.; Yan B.-S.; Hong Q.-S.; Singh S.; Kao C.-L.; Chen H.-Y.; KANG-YI SU ; Li K.-C.; Cheng C.-L.; Cheng H.-W.; Lee J.-Y.; Lee C.-N.; Yang P.-C. | Journal Article | 105 | 101 | |
| 2018 | FAM198B is associated with prolonged survival and inhibits metastasis in lung adenocarcinoma via blockage of ERK-Mediated MMP-1 expression | Hsu C.-Y.; Chang G.-C.; Chen Y.-J.; Hsu Y.-C.; Hsiao Y.-J.; KANG-YI SU ; Chen H.-Y.; Lin C.-Y.; Chen J.-S.; Chen Y.-J.; Hong Q.-S.; Ku W.-H.; Wu C.-Y.; Ho B.-C.; Chiang C.-C.; Yang P.-C.; Yu S.-L. | Journal Article | 4 | 4 | |
| 2017 | Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non–small cell lung cancer patients | Pan S.-H.; KANG-YI SU ; Spiessens B.; Kusuma N.; Delahaye N.F.; Gruselle O.; Myo A.; de Creus A.; Louahed J.; Chang G.-C.; Yu S.-L.; Yang P.-C. | Journal Article | 2 | 2 | |
| 2019 | High PD-L1 expression correlates with primary resistance to EGFR-TKIs in treatment na?ve advanced EGFR-mutant lung adenocarcinoma patients | Hsu K.-H.; Huang Y.-H.; Tseng J.-S.; Chen K.-C.; Ku W.-H.; KANG-YI SU ; Chen J.J.W.; Chen H.-W.; Yu S.-L.; Yang T.-Y.; Chang G.-C. | Journal Article | 8 | 9 |
